These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34998206)

  • 21. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
    Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
    Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy in ovarian cancer.
    Bhardwaj BK; Thankachan S; Venkatesh T; Suresh PS
    Clin Chim Acta; 2020 Nov; 510():28-34. PubMed ID: 32622965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor cells as a "real-time liquid biopsy": Recent advances and the application in ovarian cancer.
    Jou HJ; Ling PY; Hsu HT
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):34-39. PubMed ID: 35181043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer.
    Wang W; Jo H; Park S; Kim H; Kim SI; Han Y; Lee J; Seol A; Kim J; Lee M; Lee C; Dhanasekaran DN; Ahn T; Song YS
    Cancer Lett; 2022 Aug; 542():215735. PubMed ID: 35569696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence and diagnostic value of circulating tsncRNA for ovarian tumor.
    Peng EY; Shu Y; Wu Y; Zeng F; Tan S; Deng Y; Deng Y; Chen H; Zhu L; Xu H
    Mol Cancer; 2018 Nov; 17(1):163. PubMed ID: 30466461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of combining salivary mRNAs and carcinoembryonic antigen for ovarian cancer detection.
    Yang J; Xiang C; Liu J
    Scand J Clin Lab Invest; 2021 Feb; 81(1):39-45. PubMed ID: 33300816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.
    Chen SN; Chang R; Lin LT; Chern CU; Tsai HW; Wen ZH; Li YH; Li CJ; Tsui KH
    Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 30. Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.
    Bahar-Shany K; Barnabas GD; Deutsch L; Deutsch N; Glick-Saar E; Dominissini D; Sapoznik S; Helpman L; Perri T; Blecher A; Katz G; Yagel I; Rosenblatt O; Shai D; Brandt B; Meyer R; Mohr-Sasson A; Volodarsky-Perel A; Zilberman I; Armon S; Jakobson-Setton A; Eitan R; Kadan Y; Beiner M; Josephy D; Brodsky M; Friedman E; Anafi L; Molchanov Y; Korach J; Geiger T; Levanon K
    Int J Cancer; 2023 Feb; 152(4):781-793. PubMed ID: 36214786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
    Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
    Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study.
    Douvdevani A; Bernstein-Molho R; Asraf K; Doolman R; Laitman Y; Friedman E
    Cancer Biomark; 2020; 28(3):269-273. PubMed ID: 32280079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.
    Sharma S; Salomon C
    Methods Mol Biol; 2020; 2055():181-199. PubMed ID: 31502152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma.
    Lee YH; Kim JH; Zhou H; Kim BW; Wong DT
    J Mol Med (Berl); 2012 Apr; 90(4):427-34. PubMed ID: 22095100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
    Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
    Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.
    Madden SF; Clarke C; Stordal B; Carey MS; Broaddus R; Gallagher WM; Crown J; Mills GB; Hennessy BT
    Mol Cancer; 2014 Oct; 13():241. PubMed ID: 25344116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
    Tomasetti M; Amati M; Neuzil J; Santarelli L
    Lung Cancer; 2017 May; 107():65-72. PubMed ID: 27312601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
    Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
    Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.